Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A

被引:11
作者
Campbell, M. [1 ,2 ]
Anderson, P. [1 ]
Trimble, E. R. [1 ,2 ]
机构
[1] Queens Univ Belfast, Diabet Res Grp, Belfast BT12 6BJ, Antrim, North Ireland
[2] Belfast Hosp Trust, Clin Biochem, Belfast, Antrim, North Ireland
关键词
atherosclerosis; diabetes; ERK; extracellular-regulated protein kinase; PDGF-BB; PKC; platelet-derived growth factor-BB;
D O I
10.1007/s00125-008-0962-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis Atherosclerosis, which occurs prematurely in individuals with diabetes, incorporates vascular smooth muscle cell (VSMC) chemotaxis. Glucose, through protein kinase C-beta(II) signalling, increases chemotaxis to low concentrations of platelet-derived growth factor (PDGF)-BB. In VSMC, a biphasic response in PDGF-beta receptor (PDGF-beta R) level occurs as PDGF-BB concentrations increase. The purpose of this study was to determine whether increased concentrations of PDGF-BB and raised glucose level had a modulatory effect on the mitogen-activated protein kinase/extracellular-regulated protein kinase pathway, control of PDGF-beta R level and chemotaxis. Methods Cultured aortic VSMC, exposed to normal glucose (NG) (5 mmol/l) or high glucose (HG) (25 mmol/l) in the presence of PDGF-BB, were assessed for migration (chemotaxis chamber) or else extracted and immunoblotted. Results At concentrations of PDGF-BB < 540 pmol/l, HG caused an increase in the level of PDGF-beta R in VSMC (immunoblotting) versus NG, an effect that was abrogated by inhibition of aldose reductase or protein kinase C-beta(II). At higher concentrations of PDGF-BB (> 540 pmol/l) in HG, receptor level was reduced but in the presence of aldose reductase or protein kinase C-beta(II) inhibitors the receptor levels increased. It is known that phosphatases may be activated at high concentrations of growth factors. At high concentrations of PDGF-BB, the protein phosphatase (PP)2A inhibitor, endothall, caused an increase in PDGF-beta R levels and a loss of biphasicity in receptor levels in HG. At higher concentrations of PDGF-BB in HG, the chemoattractant effect of PDGF-BB was lost (chemotaxis chamber). Under these conditions inhibition of PP2A was associated with a restoration of chemotaxis to high concentrations of PDGF-BB. Conclusion/interpretation The biphasic response in PDGF-beta R level and in chemotaxis to PDGF-BB in HG is due to PP2A activation.
引用
收藏
页码:1068 / 1080
页数:13
相关论文
共 39 条
[1]   ISOLATION AND CHARACTERIZATION OF THE MOUSE PDGF BETA-RECEPTOR PROMOTER [J].
BALLAGI, AE ;
ISHIZAKI, A ;
NEHLIN, JO ;
FUNA, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (01) :165-173
[3]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[4]   Modification of PI3K-and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CβII [J].
Campbell, M ;
Trimble, ER .
CIRCULATION RESEARCH, 2005, 96 (02) :197-206
[5]   Glucose-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase-dependent upregulation of the platelet-derived growth factor-β receptor potentiates vascular smooth muscle cell chemotaxis [J].
Campbell, M ;
Allen, WE ;
Silversides, JA ;
Trimble, ER .
DIABETES, 2003, 52 (02) :519-526
[6]   Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways [J].
Campbell, M ;
Allen, WE ;
Sawyer, C ;
Vanhaesebroeck, B ;
Trimble, ER .
CIRCULATION RESEARCH, 2004, 95 (04) :380-388
[7]  
CHEN J, 1994, J BIOL CHEM, V269, P7957
[8]  
Cho HM, 2005, MOL CELLS, V19, P60
[9]   Genetic analysis of aldose reductase in diabetic complications [J].
Chung, SSM ;
Chung, SK .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (15) :1375-1387
[10]   Platelet-derived growth factor beta-receptors can both promote and inhibit chemotaxis in human vascular smooth muscle cells [J].
Clunn, GF ;
Refson, JS ;
Lymn, JS ;
Hughes, AD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2622-2629